The expression of epidermal growth factor receptor (EGFR) and its mutated form EGRRvIII has been reported in patients with a brain tumour, but none of their inhibitors has been approved for the treatment of patients with a brain tumour. This evidence concerns the gene EGFR and brain neoplasm.